Chronic Lymphocytic Leukemia-CLL

Chronic Lymphocytic Leukemia (CLL) is a type of blood and bone marrow cancer that primarily affects B lymphocytes.

It develops slowly, often discovered during routine blood tests, and commonly affects older adults.

Overview And Clinical Background

CLL results from abnormal proliferation of B lymphocytes that accumulate in the blood and bone marrow.

It’s a chronic condition with varying progression rates.

Nature:Indolent leukemia that can remain stable for years.

Cell type:Affects mature B lymphocytes responsible for antibody production.

Early diagnosis helps in monitoring and delaying progression.

Many patients are asymptomatic initially; symptoms arise as disease progresses.

Fatigue and infections are common.

Common symptom:Fatigue, enlarged lymph nodes, and night sweats.

Frequent infections or easy bruising.

Red flag:Rapid lymph node growth or unexplained weight loss.

Diagnosis is based on blood tests, flow cytometry, and genetic analysis.

Imaging helps in staging and treatment planning.

Imaging:CT scan for lymph node or spleen enlargement.

Lab tests:Complete blood count, immunophenotyping, and cytogenetic analysis.

Bone marrow biopsy confirms infiltration of abnormal lymphocytes.

Not all CLL cases need immediate treatment.

Targeted drugs and immunotherapy are common first-line options.

Watchful waiting:Monitoring until disease shows progression.

Targeted therapy:BTK inhibitors and monoclonal antibodies for active cases.

Stem cell transplantation in selected younger patients.

Many live for years with stable CLL.

Targeted therapy improves survival with minimal side effects.

CureU Healthcare provides molecular-level diagnostics and personalized CLL treatment by expert hematologists.

CLL is manageable with modern medicine and regular follow-up.

Long-term care ensures stability and quality of life.